Approval · Notice of Compliance 5237 · 1995
ELDEPRYL: Notice of Compliance 5237
Issued October 16, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5237
- Date
- October 16, 1995
- Company
- Draxis Health Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Antiparkinsonian agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELDEPRYL | 02180731 | — |
Medicinal ingredients
- SELEGILINE HYDROCHLORIDE 1 MG per ML